ROLE OF PLATELET-ACTIVATING-FACTOR IN HEMODIALYSIS

被引:0
|
作者
TETTA, C
DAVID, S
BIANCONE, L
CANINO, F
CAMBI, V
CAMUSSI, G
机构
[1] UNIV PARMA, CATTEDRA NEFROL, I-43100 PARMA, ITALY
[2] NAPLES UNIV, FAC MED & CHIRURG, CATTEDRA NEFROL SPERIMENTALE, I-80138 NAPLES, ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A complex array of inflammatory mediators are generated as a consequence of blood contact with hemodialysis (HD) membranes. Beside complement activation, other mediators are involved in cell activation, and are thought possibly to be responsible for early and long-term multiple changes in immunity infection, hypercatabolism, beta2-microglobulin generation and hemostatic mechanisms. Previous studies from our laboratories have established platelet activating factor (PAF) as one of the mediators generated by complement-dependent or independent mechanisms of cell interaction with hemodialysis membranes. Recent studies on the production of PAF from endotoxin-primed polymorphonuclear neutrophils in a closed miniaturized circuit, and on the effect of PAF in mediating endotoxin- and cytokine-induced leukocyte adherence to HD membranes, highlight so far undescribed new roles of this mediator in biocompatibility.
引用
收藏
页码:S154 / S157
页数:4
相关论文
共 50 条
  • [41] THE ROLE OF PLATELET-ACTIVATING-FACTOR IN FETAL LUNG MATURATION AND PARTURITION
    JOHNSTON, JM
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 101 - 102
  • [42] INACTIVATION BY PLASMA OF PLATELET-ACTIVATING-FACTOR
    SATOH, K
    TAKAMATSU, S
    ACTA HAEMATOLOGICA JAPONICA, 1986, 49 (03): : 711 - 716
  • [43] PLATELET-ACTIVATING-FACTOR - A MEDIATOR FOR CLINICIAN
    IMAIZUMI, TA
    STAFFORINI, DM
    YAMADA, Y
    MCINTYRE, TM
    PRESCOTT, SM
    ZIMMERMAN, GA
    JOURNAL OF INTERNAL MEDICINE, 1995, 238 (01) : 5 - 20
  • [44] PERSPECTIVES IN PLATELET-ACTIVATING-FACTOR RESEARCH
    BRAQUET, P
    TOUQUI, L
    SHEN, TY
    VARGAFTIG, BB
    PHARMACOLOGICAL REVIEWS, 1987, 39 (02) : 97 - 145
  • [45] PLATELET-ACTIVATING-FACTOR, KETOTIFEN AND ASTHMA
    PAGE, CP
    NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (812) : 818 - 818
  • [46] CARDIOVASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR
    HOLLAND, MR
    MCINTYRE, TM
    ZIMMERMAN, GA
    PRESCOTT, SM
    TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (03) : 117 - 121
  • [47] THE EFFECT OF PLATELET-ACTIVATING-FACTOR ON OVULATION
    KIKUKAWA, Y
    ISHIKAWA, M
    SENGOKU, K
    KASAMO, M
    SHIMIZU, T
    PROSTAGLANDINS, 1991, 42 (02): : 95 - 104
  • [48] THE PLATELET-ACTIVATING-FACTOR IN THE PATHOPHYSIOLOGY OF ASTHMA
    LAZARO, JF
    MACIAS, MH
    RUIZ, JP
    MEDICINA CLINICA, 1991, 96 (01): : 30 - 34
  • [49] PLATELET-ACTIVATING-FACTOR IN HUMAN ENDOMETRIUM
    BALDI, E
    BONACCORSI, L
    FINETTI, G
    LUCONI, M
    MURATORI, M
    SUSINI, T
    FORTI, G
    SERIO, M
    MAGGI, M
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6): : 359 - 363
  • [50] PLATELET-ACTIVATING-FACTOR, KETOTIFEN AND ASTHMA
    NEWHOUSE, MT
    SEARS, MR
    NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (808) : 641 - 641